1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Hepatic Insufficiency Global Clinical Trials Review, H1, 2015

Hepatic Insufficiency Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Hepatic Insufficiency Global Clinical Trials Review, H1, 2015" provides data on the Hepatic Insufficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatic Insufficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatic Insufficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Hepatic Insufficiency Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hepatic Insufficiency 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hepatic Insufficiency 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Hepatic Insufficiency Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Merck and Co., Inc. 31
Clinical Trial Overview of Merck and Co., Inc. 31
Novartis AG 32
Clinical Trial Overview of Novartis AG 32
Eli Lilly and Company 33
Clinical Trial Overview of Eli Lilly and Company 33
Puma Biotechnology, Inc. 34
Clinical Trial Overview of Puma Biotechnology, Inc. 34
Johnson and Johnson 35
Clinical Trial Overview of Johnson and Johnson 35
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
C. H. Boehringer Sohn AG and Co. KG 37
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 37
Pfizer Inc. 38
Clinical Trial Overview of Pfizer Inc. 38
Bristol-Myers Squibb Company 39
Clinical Trial Overview of Bristol-Myers Squibb Company 39
Astellas Pharma Europe Ltd. 40
Clinical Trial Overview of Astellas Pharma Europe Ltd. 40
Clinical Trial Overview of Top Institutes / Government 41
Copenhagen University Hospital Gentofte 41
Clinical Trial Overview of Copenhagen University Hospital Gentofte 41
National Cancer Institute 42
Clinical Trial Overview of National Cancer Institute 42
Aarhus University 43
Clinical Trial Overview of Aarhus University 43
Donau-Universitat Krems 44
Clinical Trial Overview of Donau-Universitat Krems 44
Huashan Hospital 45
Clinical Trial Overview of Huashan Hospital 45
Mayo Clinic 46
Clinical Trial Overview of Mayo Clinic 46
McGill University Health Center 47
Clinical Trial Overview of McGill University Health Center 47
Five Key Clinical Profiles 48
Appendix 73
Abbreviations 73
Definitions 73
Research Methodology 74
Secondary Research 74
About GlobalData 75
Contact Us 75
Disclaimer 75
Source 75

List of Tables
Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Region, 2015* 7
Hepatic Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Hepatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Hepatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Hepatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Hepatic Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Hepatic Insufficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Hepatic Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Hepatic Insufficiency Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 31
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 32
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 33
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Puma Biotechnology, Inc., 2015* 34
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2015* 35
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 36
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2015* 37
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 38
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015* 39
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Europe Ltd., 2015* 40
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Copenhagen University Hospital Gentofte, 2015* 41
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 42
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2015* 43
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Donau-Universitat Krems, 2015* 44
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Huashan Hospital, 2015* 45
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 46
Hepatic Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University Health Center, 2015* 47

List of Figures
Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Hepatic Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Hepatic Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Hepatic Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Hepatic Insufficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Hepatic Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Hepatic Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Hepatic Insufficiency to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Hepatic Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Hepatic Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Hepatic Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Hepatic Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Hepatic Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Hepatic Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 74

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.